pI: 8.3532 |
Length (AA): 398 |
MW (Da): 45751 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
10 | 178 | 4uos (A) | 18 | 186 | 12.00 | 0 | 0.01 | 0.668123 | -1.54 |
23 | 134 | 2fxo (A) | 840 | 958 | 15.00 | 0.15 | 0.01 | 0.421507 | -0.63 |
101 | 175 | 4b1z (M) | 425 | 515 | 37.00 | 0.37 | 0.07 | 0.345642 | 0.03 |
313 | 372 | 5lsl (E) | 290 | 346 | 42.00 | 0 | 0.91 | 0.574254 | -0.74 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128039)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G21660 | proline-rich spliceosome-associated (PSP) family protein |
Babesia bovis | BBOV_IV002140 | splicing factor 3B subunit 2 |
Brugia malayi | Bm1_57395 | splicing factor 3b, subunit 2 |
Candida albicans | CaO19.7581 | similar to C terminus of human spliceosome U2 snRNP protein SAP145 aka SF3B |
Caenorhabditis elegans | CELE_W03F9.10 | Protein W03F9.10 |
Cryptosporidium hominis | Chro.20372 | spliceosome associated protein-like |
Cryptosporidium parvum | cgd2_3510 | Cus1p U2 snRNP protein |
Dictyostelium discoideum | DDB_G0284555 | PSP proline-rich domain-containing protein |
Drosophila melanogaster | Dmel_CG3605 | CG3605 gene product from transcript CG3605-RB |
Echinococcus granulosus | EgrG_000523600 | splicing factor 3b subunit 2 |
Entamoeba histolytica | EHI_069550 | splicing factor3B subunit 2, putative |
Echinococcus multilocularis | EmuJ_000523600 | splicing factor 3b subunit 2 |
Giardia lamblia | GL50803_17126 | Hypothetical protein |
Homo sapiens | ENSG00000087365 | splicing factor 3b, subunit 2, 145kDa |
Leishmania braziliensis | LbrM.30.0650 | spliceosome-associated protein, putative |
Leishmania donovani | LdBPK_300590.1 | spliceosome-associated protein, putative |
Leishmania infantum | LinJ.30.0590 | spliceosome-associated protein, putative |
Leishmania major | LmjF.30.0570 | spliceosome-associated protein, putative |
Leishmania mexicana | LmxM.29.0570 | spliceosome-associated protein, putative |
Loa Loa (eye worm) | LOAG_01491 | splicing factor 3b |
Mus musculus | ENSMUSG00000024853 | splicing factor 3b, subunit 2 |
Neospora caninum | NCLIV_057640 | mRNA splicing factor 3bA, related |
Oryza sativa | 4331222 | Os02g0827300 |
Onchocerca volvulus | OVOC7388 | Splicing factor 3B subunit 2 homolog |
Plasmodium berghei | PBANKA_1325300 | splicing factor 3B subunit 2, putative |
Plasmodium falciparum | PF3D7_1461600 | splicing factor 3B subunit 2, putative |
Plasmodium knowlesi | PKNH_1220100 | splicing factor 3B subunit 2, putative |
Plasmodium vivax | PVX_117375 | splicing factor 3B subunit 2, putative |
Plasmodium yoelii | PY04139 | Unknown-related |
Saccharomyces cerevisiae | YMR240C | Cus1p |
Schistosoma japonicum | Sjp_0007110 | Splicing factor 3B subunit 2, putative |
Schistosoma mansoni | Smp_096810.2 | hypothetical protein |
Schistosoma mansoni | Smp_096810.1 | hypothetical protein |
Schmidtea mediterranea | mk4.000032.09 | |
Schmidtea mediterranea | mk4.000796.03 | |
Trypanosoma brucei gambiense | Tbg972.6.1720 | spliceosome-associated protein, putative |
Trypanosoma brucei | Tb927.6.2000 | spliceosome-associated protein, putative |
Trypanosoma congolense | TcIL3000_6_1580 | spliceosome-associated protein, putative |
Trypanosoma cruzi | TcCLB.504071.50 | spliceosome-associated protein, putative |
Toxoplasma gondii | TGME49_314740 | PSP protein |
Theileria parva | TP03_0436 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_081790 | cus1 protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.2000 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.2000 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.2000 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.2000 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_W03F9.10 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_W03F9.10 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_W03F9.10 | Caenorhabditis elegans | slow growth | wormbase |
CELE_W03F9.10 | Caenorhabditis elegans | sterile | wormbase |
YMR240C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1325300 | Plasmodium berghei | Slow | plasmo |
TGME49_314740 | Toxoplasma gondii | Probably essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.